☰

Brian P. Hobbs, Ph.D. - Publications

Affiliations: 
2010 Biostatistics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Biostatistics Biology, Statistics, Public Health
Tree Info Similar researchers PubMed Report error

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V, Jia X, Goldstein N, Recht A. The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis. Annals of Surgical Oncology. PMID 32712894 DOI: 10.1245/S10434-020-08878-9  0.321
2020 Pestana RC, Sen S, Hobbs BP, Hong DS. Histology-agnostic drug development - considering issues beyond the tissue. Nature Reviews. Clinical Oncology. PMID 32528101 DOI: 10.1038/S41571-020-0384-0  0.343
2020 Statler AB, Wei W, Gupta A, Blake CN, Hobbs BP, Nahleh ZA. Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis. Clinical Breast Cancer. PMID 32434711 DOI: 10.1016/J.Clbc.2020.04.002  0.303
2020 Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, et al. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902503. PMID 32160096 DOI: 10.1200/Jco.19.02503  0.357
2020 Ahluwalia MS, Peereboom DM, Ciolfi M, Schilero C, Hobbs B, Ciesielski MJ, Fenstermaker RA. Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence. Journal of Clinical Oncology. 38: TPS2581-TPS2581. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2581  0.353
2020 Sussman TA, Wei W, Hobbs B, Diaz-Montero CM, Ni Y, Arbesman J, Ko JS, Gastman B, Funchain P. A phase II trial of nivolumab in combination with talazoparib in unresectable or metastatic melanoma patients with mutations in BRCA or BRCAness. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps10082  0.306
2020 Ornstein MC, Zabell J, Wood LS, Hobbs B, Devonshire S, Martin A, Allman KD, Rao A, Gilligan TD, Campbell S, Krishnamurthi V, Rini BI. A phase Ib trial of neoadjuvant/adjuvant durvalumab +/- tremelimumab in locally advanced renal cell carcinoma (RCC). Journal of Clinical Oncology. 38: 5021-5021. DOI: 10.1200/Jco.2020.38.15_Suppl.5021  0.313
2019 Statler AB, Hobbs BP, Wei W, Gupta A, Blake CN, Nahleh ZA. Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis. Scientific Reports. 9: 18126. PMID 31792304 DOI: 10.1038/S41598-019-54402-9  0.361
2019 Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31479748 DOI: 10.1016/J.Jtho.2019.08.2505  0.339
2019 Ornstein MC, Wood LS, Hobbs BP, Allman KD, Martin A, Bevan M, Gilligan TD, Garcia JA, Rini BI. A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy. Journal For Immunotherapy of Cancer. 7: 127. PMID 31097024 DOI: 10.1186/S40425-019-0615-Z  0.34
2019 Patil PD, Hobbs B, Pennell NA. The promise and challenges of deep learning models for automated histopathologic classification and mutation prediction in lung cancer. Journal of Thoracic Disease. 11: 369-372. PMID 30962976 DOI: 10.21037/Jtd.2018.12.55  0.3
2019 Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, Raymond D, Abraham J, Klein EA, Walsh RM, Monteleone EE, Wei W, Hobbs B, Bolwell BJ. Time to initial cancer treatment in the United States and association with survival over time: An observational study. Plos One. 14: e0213209. PMID 30822350 DOI: 10.1371/Journal.Pone.0213209  0.323
2019 Ma J, Stingo FC, Hobbs BP. Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants. Biometrical Journal. Biometrische Zeitschrift. PMID 30786040 DOI: 10.1002/Bimj.201700323  0.314
2019 Wang Y, Hu J, Ng CS, Hobbs BP. A functional model for classifying metastatic lesions integrating scans and biomarkers. Statistical Methods in Medical Research. 962280218823795. PMID 30672395 DOI: 10.1177/0962280218823795  0.349
2019 Nahleh ZA, Hobbs B, Elimimian E, Wei W(, Gupta A, Blake CN. Patterns of systemic treatment utilization in ER+/PgR+/HER2+, early-stage breast cancer (BC): An analysis of the National Cancer Database. Journal of Clinical Oncology. 37: 547-547. DOI: 10.1200/Jco.2019.37.15_Suppl.547  0.308
2019 Statler A, Gupta A, Blake CN, Wei W(, Hobbs BP, Nahleh ZA. Disparities in treatment patterns and overall survival (OS) in hormone receptor-positive HER2+ metastatic breast cancer (MBC): A National Cancer Database Analysis. Journal of Clinical Oncology. 37: 1032-1032. DOI: 10.1200/Jco.2019.37.15_Suppl.1032  0.306
2019 Lin S, Hobbs B, Thall P, Tidwell R, Wei X, Komaki R, Chang J, Chun S, Jeter M, Hahn S, Swisher S, Ajani J, Murphy M, Vaporciyan A, Mehran R, et al. Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: 680-681. DOI: 10.1016/J.Ijrobp.2019.08.030  0.323
2019 Rossum PSNv, Fang P, Musall B, Son JB, Fellman B, Hobbs B, Ma J, Lin SH. Final Trial Results of Repeated Diffusion-Weighted MRI and FDG-PET Imaging for the Prediction of Response to Chemoradiation Therapy in Esophageal Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.498  0.335
2018 Li X, Guindani M, Ng CS, Hobbs BP. Spatial Bayesian modeling of GLCM with application to malignant lesion characterization. Journal of Applied Statistics. 46: 230-246. PMID 31439980 DOI: 10.1080/02664763.2018.1473348  0.318
2018 Hobbs BP, Barata PC, Kanjanapan Y, Paller CJ, Perlmutter J, Pond GR, Prowell TM, Rubin EH, Seymour LK, Wages NA, Yap TA, Feltquate D, Garrett-Mayer E, Grossman W, Hong DS, et al. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. Journal of the National Cancer Institute. PMID 30561713 DOI: 10.1093/Jnci/Djy196  0.36
2018 Hobbs BP, Kane MJ, Hong DS, Landin R. Statistical challenges posed by uncontrolled master protocols: sensitivity analysis of the Vemurafenib study. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30335125 DOI: 10.1093/Annonc/Mdy457  0.391
2018 Huang M, Hobbs BP. Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies. Statistical Methods in Medical Research. 962280218788099. PMID 30037304 DOI: 10.1177/0962280218788099  0.35
2018 Hobbs BP, Landin R. Bayesian basket trial design with exchangeability monitoring. Statistics in Medicine. PMID 29984488 DOI: 10.1002/Sim.7893  0.397
2018 Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, et al. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Scientific Reports. 8: 1922. PMID 29386574 DOI: 10.1038/S41598-018-20471-5  0.32
2018 Kaizer AM, Hobbs BP, Koopmeiners JS. A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics. PMID 29359450 DOI: 10.1111/Biom.12841  0.357
2018 Roopkumar J, Kim AS, Bicky T, Hobbs BP, Khorana AA. Venous Thromboembolism in Cancer Patients Receiving Immunotherapy Blood. 132: 2510-2510. DOI: 10.1182/Blood-2018-99-116439  0.308
2018 Waldron M, Siebenaller C, Hobbs BP, Earl M, Schleicher M, Carraway HE, Advani AS, Nazha A, Gerds AT, Hamilton BK, Sobecks R, Kalaycio M, Sekeres MA, Mukherjee S. Risk of Venous Thromboembolism in Acute Leukemias: A Meta-Analysis Blood. 132: 4805-4805. DOI: 10.1182/Blood-2018-99-115256  0.318
2018 Barata P, Hobbs B, Rini B, Paller C, Normolle D, Garrett-Mayer E, Rubin E, Rosner G, Pond G, Perlmutter J, Seymour L, Siu L, Wages N, Ivy P, Prowell T, et al. Abstract A100: Seamless phase I/II clinical trials in oncology: retrospective analysis of the last 7 years Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A100  0.364
2018 Chen N, Carlin BP, Hobbs BP. Web-based statistical tools for the analysis and design of clinical trials that incorporate historical controls Computational Statistics & Data Analysis. 127: 50-68. DOI: 10.1016/J.Csda.2018.05.002  0.583
2017 Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JY. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29246722 DOI: 10.1016/J.Ijrobp.2017.10.046  0.311
2017 Kaizer AM, Koopmeiners JS, Hobbs BP. Bayesian hierarchical modeling based on multisource exchangeability. Biostatistics (Oxford, England). PMID 29036300 DOI: 10.1093/Biostatistics/Kxx031  0.324
2017 Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs B, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach J, et al. RAD50 expression is associated with poor clinical outcomes after radiotherapy for resected non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29030353 DOI: 10.1158/1078-0432.Ccr-17-1455  0.322
2017 Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang M, Komaki R, Lin SH. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old. International Journal of Radiation Oncology, Biology, Physics. 98: 811-819. PMID 28602412 DOI: 10.1016/J.Ijrobp.2017.02.097  0.344
2017 Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, et al. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Annals of Surgery. PMID 28549010 DOI: 10.1097/Sla.0000000000002313  0.315
2017 Shiraishi Y, Xu C, Song J, Komaki R, Hobbs BP, Lin SH. The impact of proton beam therapy on blood cell count nadir during neoadjuvant chemoradiation therapy for esophageal cancer. Journal of Clinical Oncology. 35: 137-137. DOI: 10.1200/Jco.2017.35.4_Suppl.137  0.343
2017 Sandulache VC, Mohamed ASR, Chen Y, Hutcheson KA, Hobbs BP, Chambers MS, Johnson JM, Williams MD, Bankson JA, Fuller CD, Lai SY. Abstract IA14: Optimizing head and neck cancer treatment outcomes with MRI Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Ia14  0.497
2017 Kuerer H, Rauch G, Krishnamurthy S, Adrada B, Caudle A, DeSnyder S, Santiago L, Lucci A, Hobbs B, Gilcrease M, Hwang R, Candelaria R, Mac-Gregor MC, Arribas E, Moseley T, et al. Abstract P5-16-30: Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-16-30  0.318
2017 Lin SH, Xu C, Xi M, Deng W, Shiraishi Y, Murphy MB, Hofstetter W, Ho L, Hobbs B, Huang M, Liao Z, Komaki RU. Toxicities and Clinical Outcomes of Concurrent Chemoradiation Therapy with 5-Fluorouracil Combined With Either Platinum or Taxanes for Localized Esophageal Cancer: A Propensity Score Matched Analysis International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1079  0.343
2017 Fang P, Shiraishi Y, Jiang W, Song J, Hobbs BP, Lin S. (S019) Lymphocyte-Sparing Effect of Proton Therapy in Patients With Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 98: E6. DOI: 10.1016/J.Ijrobp.2017.02.055  0.316
2016 Zhao H, Hobbs BP, Ma H, Jiang Q, Carlin BP. Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors. Health Services & Outcomes Research Methodology. 16: 154-171. PMID 28458614 DOI: 10.1007/S10742-016-0155-7  0.679
2016 Ma J, Hobbs BP, Stingo FC. Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Statistical Methods in Medical Research. PMID 27807177 DOI: 10.1177/0962280216675373  0.365
2016 Mohamed AS, Lai SY, Murri M, Hutcheson KA, Sandulache VC, Hobbs B, Gunn GB, Garg N, Chambers MS, Frank SJ, Rosenthal DI, Garden AS, Fuller CD. Dose-Volume Correlates of Osteoradionecrosis of the Mandible in Oropharynx Patients Receiving Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S220-S221. PMID 27675829 DOI: 10.1016/J.Ijrobp.2016.06.548  0.45
2016 Koopmeiners JS, Hobbs BP. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials. Statistical Methods in Medical Research. PMID 27587591 DOI: 10.1177/0962280216665418  0.365
2016 Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. The Laryngoscope. PMID 27440393 DOI: 10.1002/Lary.26153  0.453
2016 Murray TA, Hobbs BP, Sargent DJ, Carlin BP. Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects. Bayesian Analysis. 11: 381-402. PMID 27042243 DOI: 10.1214/15-Ba954  0.575
2016 Hobbs BP, Thall PF, Lin SH. Bayesian Group Sequential Clinical Trial Design using Total Toxicity Burden and Progression-Free Survival. Journal of the Royal Statistical Society. Series C, Applied Statistics. 65: 273-297. PMID 27034510 DOI: 10.1111/Rssc.12117  0.388
2016 Hobbs BP, Chen N, Lee JJ. Controlled multi-arm platform design using predictive probability. Statistical Methods in Medical Research. PMID 26763586 DOI: 10.1177/0962280215620696  0.345
2016 Skinner HD, Guerrero T, Hobbs B, Court L, Nitsch PL, Heymach J. Abstract CT075: Tumor mutation status will predict metabolic response to metformin in lung cancer treated with stereotactic body radiation therapy (SBRT) Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct075  0.378
2016 Sandulache VC, Hobbs BP, Mohamed RAS, Frank SJ, Song J, Ding Y, Ger R, Court LE, Kalpathy-Cramer J, Hazle JD, Wang J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, et al. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: Prospective assessment of imaging biomarkers of normal tissue injury Scientific Reports. 6. DOI: 10.1038/Srep29864  0.471
2016 Sandulache VC, Hobbs B, Mohamed ASR, Frank SJ, Hazle J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, Ding Y, Wang J, Colen R, Hutcheson KA, Lewin JS, Chambers MS, et al. Dynamic Contrast-Enhanced MRI Detects Acute Radiation Therapy–Induced Alterations in Mandibular Microvasculature: Prospective Assessment of Imaging Biomarkers of Normal Tissue Injury International Journal of Radiation Oncology Biology Physics. 94: 924. DOI: 10.1016/J.Ijrobp.2015.12.173  0.431
2015 Fronczyk KM, Guindani M, Hobbs BP, Ng CS, Vannucci M. A Bayesian Nonparametric Approach for Functional Data Classification with Application to Hepatic Tissue Characterization. Cancer Informatics. 14: 151-62. PMID 27279730 DOI: 10.4137/Cin.S31933  0.323
2015 Ma J, Stingo FC, Hobbs BP. Bayesian predictive modeling for genomic based personalized treatment selection. Biometrics. PMID 26575856 DOI: 10.1111/Biom.12448  0.344
2015 Murray TA, Hobbs BP, Carlin BP. COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORS. The Annals of Applied Statistics. 9: 1549-1570. PMID 26557211 DOI: 10.1214/15-Aoas840  0.603
2015 Wang Y, Hobbs BP, Ng CS. CT Perfusion Characteristics Identify Metastatic Sites in Liver. Biomed Research International. 2015: 120749. PMID 26509144 DOI: 10.1155/2015/120749  0.31
2015 Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. Nmr in Biomedicine. PMID 26451969 DOI: 10.1002/Nbm.3412  0.468
2015 Ma J, Hobbs BP, Stingo FC. Statistical Methods for Establishing Personalized Treatment Rules in Oncology. Biomed Research International. 2015: 670691. PMID 26446492 DOI: 10.1155/2015/670691  0.312
2015 Raghav KP, Mahajan S, Yao JC, Hobbs BP, Berry DA, Pentz RD, Tam A, Hong WK, Ellis LM, Abbruzzese J, Overman MJ. From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26304898 DOI: 10.1200/Jco.2015.62.4148  0.332
2015 Castillo SJ, Castillo R, Castillo E, Pan T, Ibbott G, Balter P, Hobbs B, Guerrero T. Evaluation of 4D CT acquisition methods designed to reduce artifacts. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 16: 4949. PMID 26103169 DOI: 10.1120/Jacmp.V16I2.4949  0.329
2015 Hobbs BP, Ng CS. Inferring Stable Acquisition Durations for Applications of Perfusion Imaging in Oncology. Cancer Informatics. 14: 193-9. PMID 26052222 DOI: 10.4137/Cin.S17280  0.32
2015 Wang Y, Hobbs BP, Hu J, Ng CS, Do KA. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics. PMID 25851056 DOI: 10.1111/Biom.12304  0.33
2015 Castillo R, Pham N, Castillo E, Aso-Gonzalez S, Ansari S, Hobbs B, Palacio D, Skinner H, Guerrero TM. Pre-radiation therapy fluorine 18 fluorodeoxyglucose pet helps identify patients with esophageal cancer at high risk for radiation pneumonitis Radiology. 275: 822-831. PMID 25584706 DOI: 10.1148/Radiol.14140457  0.362
2014 Castillo R, Pham N, Ansari S, Meshkov D, Castillo S, Li M, Olanrewaju A, Hobbs B, Castillo E, Guerrero T. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer. Radiation Oncology (London, England). 9: 74. PMID 24625207 DOI: 10.1186/1748-717X-9-74  0.318
2014 Murray TA, Hobbs BP, Lystig TC, Carlin BP. Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data. Biometrics. 70: 185-91. PMID 24308779 DOI: 10.1111/Biom.12115  0.572
2014 Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Use of historical control data for assessing treatment effects in clinical trials. Pharmaceutical Statistics. 13: 41-54. PMID 23913901 DOI: 10.1002/Pst.1589  0.344
2013 Hobbs BP, Carlin BP, Sargent DJ. Adaptive adjustment of the randomization ratio using historical control data. Clinical Trials (London, England). 10: 430-40. PMID 23690095 DOI: 10.1177/1740774513483934  0.604
2013 Meshkov D, Sheu T, Hobbs B, Castillo R, Pham N, Guerrero T, Gomez D, Liao Z. Pre-Radiation Therapy FDG PET Predicts Radiation Pneumonitis in Non-Small Cell Lung Cancer (NSCLC) Patients International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1426  0.317
2012 Hobbs BP, Sargent DJ, Carlin BP. Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models. Bayesian Analysis (Online). 7: 639-674. PMID 24795786 DOI: 10.1214/12-Ba722  0.593
2011 Hobbs BP, Carlin BP, Mandrekar SJ, Sargent DJ. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics. 67: 1047-56. PMID 21361892 DOI: 10.1111/J.1541-0420.2011.01564.X  0.596
2008 Hobbs BP, Carlin BP. Practical Bayesian design and analysis for drug and device clinical trials. Journal of Biopharmaceutical Statistics. 18: 54-80. PMID 18161542 DOI: 10.1080/10543400701668266  0.574
Show low-probability matches.